Spero Therapeutics Inc (NASDAQ: SPRO) on Tuesday, soared 3.93% from the previous trading day, before settling in for the closing price of $2.29. Within the past 52 weeks, SPRO’s price has moved between $0.51 and $3.22.
Healthcare Sector giant saw their annual sales surged by 17.67% over the last five years. The company achieved an average annual earnings per share of 63.78%. With a float of $38.59 million, this company’s outstanding shares have now reached $56.19 million.
Spero Therapeutics Inc (SPRO) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Spero Therapeutics Inc is 31.43%, while institutional ownership is 14.20%. The most recent insider transaction that took place on Aug 28 ’25, was worth 12,947. In this transaction Director of this company sold 6,572 shares at a rate of $1.97, taking the stock ownership to the 703,294 shares. Before that another transaction happened on Aug 28 ’25, when Company’s Chief Operating Officer sold 1,695 for $1.97, making the entire transaction worth $3,339. This insider now owns 739,744 shares in total.
Spero Therapeutics Inc (SPRO) Recent Fiscal highlights
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.32 earnings per share (EPS) for the period topping the consensus outlook (set at -0.36) by 0.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.22 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 63.78% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 15.36% during the next five years compared to 17.67% growth over the previous five years of trading.
Spero Therapeutics Inc (NASDAQ: SPRO) Trading Performance Indicators
Spero Therapeutics Inc (SPRO) is currently performing well based on its current performance indicators. A quick ratio of 3.97 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.93.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.98, a number that is poised to hit -0.25 in the next quarter and is forecasted to reach -0.04 in one year’s time.
Technical Analysis of Spero Therapeutics Inc (SPRO)
Analysing the last 5-days average volume posted by the [Spero Therapeutics Inc, SPRO], we can find that recorded value of 0.63 million was lower than the volume posted last year of 1.63 million. As of the previous 9 days, the stock’s Stochastic %D was 36.60%.
During the past 100 days, Spero Therapeutics Inc’s (SPRO) raw stochastic average was set at 40.85%, which indicates a significant decrease from 60.84% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.13 in the past 14 days, which was higher than the 0.12 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.07, while its 200-day Moving Average is $1.60. Now, the first resistance to watch is $2.44. This is followed by the second major resistance level at $2.51. The third major resistance level sits at $2.59. If the price goes on to break the first support level at $2.29, it is likely to go to the next support level at $2.21. Now, if the price goes above the second support level, the third support stands at $2.14.
Spero Therapeutics Inc (NASDAQ: SPRO) Key Stats
Market capitalization of the company is 133.94 million based on 56,275K outstanding shares. Right now, sales total 47,980 K and income totals -68,570 K. The company made 14,190 K in profit during its latest quarter, and -1,700 K in sales during its previous quarter.
